Home | Help | Feedback | Subscriptions | Archive | Search | Table of Contents

This Article Full Text Full Text (PDF, 1907K) PPT slides of all figures Supplemental Material Index Alert me when this article is cited Citation Map Services Email this article Similar articles in this journal Similar articles in PubMed Alert me to new content in the JEM Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via CrossRef Citing Articles via Google Scholar Google Scholar Articles by Kleinschnitz, C. Articles by Renné, T. Search for Related Content PubMed PubMed Citation Articles by Kleinschnitz, C. Articles by Renné, T. Related Collections Related Article Social Bookmarking                      What's this?

¹ Department of Neurology, ² Department of Neuroradiology, ³ Institute for Clinical Biochemistry and Pathobiochemistry, University of Würzburg, 97080 Würzburg, Germany
⁴ Department of Gynecology and Obstetrics and ⁵ Institute of Human Genetics, University of Göttingen, 37073 Göttingen, Germany
⁶ Institute for Pathology, University of Frankfurt, 60590 Frankfurt, Germany
⁷ Departments of Pathology and ⁸ Department of Medicine, Vanderbilt University School of Medicine, Nashville, TN 37232
⁹ Rudolf Virchow Center, 97078 Würzburg, Germany

CORRESPONDENCE Thomas Renné: thomas{at}renne.net

Formation of fibrin is critical for limiting blood loss at a site of blood vessel injury (hemostasis), but may also contribute to vascular thrombosis. Hereditary deficiency of factor XII (FXII), the protease that triggers the intrinsic pathway of coagulation in vitro, is not associated with spontaneous or excessive injury-related bleeding, indicating FXII is not required for hemostasis. We demonstrate that deficiency or inhibition of FXII protects mice from ischemic brain injury. After transient middle cerebral artery occlusion, the volume of infarcted brain in FXII-deficient and FXII inhibitor–treated mice was substantially less than in wild-type controls, without an increase in infarct-associated hemorrhage. Targeting FXII reduced fibrin formation in ischemic vessels, and reconstitution of FXII-deficient mice with human FXII restored fibrin deposition. Mice deficient in the FXII substrate factor XI were similarly protected from vessel-occluding fibrin formation, suggesting that FXII contributes to pathologic clotting through the intrinsic pathway. These data demonstrate that some processes involved in pathologic thrombus formation are distinct from those required for normal hemostasis. As FXII appears to be instrumental in pathologic fibrin formation but dispensable for hemostasis, FXII inhibition may offer a selective and safe strategy for preventing stroke and other thromboembolic diseases.

H.-U. Pauer's present address is Center for Hemostasis and Thrombosis Research, Vascular Biology Center, Beth Israel Deaconess Medical Center and Harvard Medical School, Boston, 02215 MA.

CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    What's this?

Related Article

Are hemostasis and thrombosis two sides of the same coin?

Robert W. Colman
J. Exp. Med. 2006 203: 493-495. [Abstract] [Full Text] [PDF]

This article has been cited by other articles:

• Stoll, G., Kleinschnitz, C., Nieswandt, B. (2008). Molecular mechanisms of thrombus formation in ischemic stroke: novel insights and targets for treatment. Blood 112: 3555-3562 [Abstract] [Full Text]  
• Furie, B., Furie, B. C. (2008). Mechanisms of Thrombus Formation. NEJM 359: 938-949 [Full Text]  
• Salomon, O., Steinberg, D. M., Koren-Morag, N., Tanne, D., Seligsohn, U. (2008). Reduced incidence of ischemic stroke in patients with severe factor XI deficiency. Blood 111: 4113-4117 [Abstract] [Full Text]  
• Kleinschnitz, C., Braeuninger, S., Pham, M., Austinat, M., Nolte, I., Renne, T., Nieswandt, B., Bendszus, M., Stoll, G. (2008). Blocking of Platelets or Intrinsic Coagulation Pathway-Driven Thrombosis Does Not Prevent Cerebral Infarctions Induced by Photothrombosis. Stroke 39: 1262-1268 [Abstract] [Full Text]  
• Gailani, D., Renne, T. (2007). Intrinsic Pathway of Coagulation and Arterial Thrombosis. Arterioscler. Thromb. Vasc. Bio. 27: 2507-2513 [Abstract] [Full Text]  
• Kleinschnitz, C., Pozgajova, M., Pham, M., Bendszus, M., Nieswandt, B., Stoll, G. (2007). Targeting Platelets in Acute Experimental Stroke: Impact of Glycoprotein Ib, VI, and IIb/IIIa Blockade on Infarct Size, Functional Outcome, and Intracranial Bleeding. Circulation 115: 2323-2330 [Abstract] [Full Text]  
• Sachs, U. J.H., Nieswandt, B. (2007). In Vivo Thrombus Formation in Murine Models. Circ. Res. 100: 979-991 [Abstract] [Full Text]  
• Kannemeier, C., Shibamiya, A., Nakazawa, F., Trusheim, H., Ruppert, C., Markart, P., Song, Y., Tzima, E., Kennerknecht, E., Niepmann, M., von Bruehl, M.-L., Sedding, D., Massberg, S., Gunther, A., Engelmann, B., Preissner, K. T. (2007). Extracellular RNA constitutes a natural procoagulant cofactor in blood coagulation. Proc. Natl. Acad. Sci. USA 104: 6388-6393 [Abstract] [Full Text]  
• Edmunds, L. H. Jr, Colman, R. W. (2006). Thrombin During Cardiopulmonary Bypass. Ann. Thorac. Surg. 82: 2315-2322 [Abstract] [Full Text]  
• Colman, R. W. (2006). Are hemostasis and thrombosis two sides of the same coin?. JEM 203: 493-495 [Abstract] [Full Text]  

Home | Help | Feedback | Subscriptions | Archive | Search

TABLE OF CONTENTS